CYNTHIA MANI: Open Payments
NPI 1497033963 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 9 payments from 6 companies in 2025. Trend: 2023 $149 · 2024 $320 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $94 |
| Organon LLC | 2 | $37 |
| Sage Therapeutics, LLC | 1 | $21 |
| Medtronic, Inc. | 1 | $19 |
| OptumHealth Care Solutions, LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: Veozah, NEXPLANON, ZURZUVAE, TRUCLEAR, VIVIFY HEALTH CARE TEAM PORTAL 001, MYFEMBREE.
Industry payments across TX — which companies pay providers there.
